🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fostering Data Sharing

Search Papers Authors Institutions Grants FAIR About

TheSindex

Fostering Data Sharing

Empowering the data sharing that empowers science — an open, citation-grounded index for datasets.

Product

Search
API
Explore
Rankings

Resources

Methodology
Data Sources
Documentation
Press

Organization

About
Team
Wikidata

© 2026 theSindex. All rights reserved.

Home
Authors
Jill Corre

Jill Corre

Centre National de la Recherche Scientifique

ORCID: 0000-0003-1580-6106

Also affiliated with Université Toulouse III - Paul Sabatier, Inserm, Centre Hospitalier Universitaire de Toulouse, Centre de Recherches en Cancérologie de Toulouse, Institut universitaire du cancer de Toulouse Oncopole

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 12 papers. Top paper: “International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma”.

International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma

Journal of Clinical Oncology(2025)10.1200/jco-24-01893

N/A

2.3DataRank · unranked

151 citations

Faith E. Davies, Mehmet Samur, Jill Corre, Mattia D’Agostino, Martin Kaiser +41 more

IgM-MM is predominantly a pre–germinal center disorder and has a distinct genomic and transcriptomic signature from WM

Blood(2021)10.1182/blood.2021011452

N/A

0.996DataRank · unranked

21 citations

Hervé Avet‐Loiseau, Raphaël Szalat, Anıl Aktaş Samur, Zachary R. Hunter, Masood A. Shammas +9 more

In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors

Blood Cancer Journal(2022)10.1038/s41408-022-00759-6

N/A

0.690DataRank · unranked

25 citations

Mariateresa Fulciniti, Hervé Avet‐Loiseau, Michael Lopez, Sanika Derebail, Jill Corre +8 more

Daratumumab, carfilzomib, lenalidomide, and dexamethasone with tandem transplant for high-risk newly diagnosed myeloma

Blood(2024)10.1182/blood.2023023597

N/A

0.617DataRank · unranked

60 citations

Aurore Perrot, Cyrille Hulin, Salomon Manier, Margaret Macro, Marie-Lorraine Chretien +11 more

High-dose melphalan treatment significantly increases mutational burden at relapse in multiple myeloma

Blood(2023)10.1182/blood.2022017094

N/A

0.584DataRank · unranked

48 citations

Marco Roncador, Anıl Aktaş Samur, Mariateresa Fulciniti, Abdul Hamid Bazarbachi, Raphaël Szalat +14 more

Improved survival in multiple myeloma during the 2005–2009 and 2010–2014 periods

Leukemia(2021)10.1038/s41375-021-01250-0

N/A

0.561DataRank · unranked

41 citations

Aurore Perrot, Cyrille Hulin, Denis Caillot, Anne‐Marie Stoppa, Thierry Façon +25 more

Immunomodulation of NK, NKT and B/T cell subtypes in relapsed/refractory multiple myeloma patients treated with pomalidomide along with velcade and dexamethasone and its association with improved progression-free survival

Frontiers in Oncology(2023)10.3389/fonc.2023.1271807

N/A

0.360DataRank · unranked

10 citations

William E. Pierceall, Mehmet Samur, Lakshmi B. Potluri, Kevin Hong, Teresa Peluso +18 more

Iberdomide, ixazomib and dexamethasone in elderly patients with multiple myeloma at first relapse

British Journal of Haematology(2025)10.1111/bjh.19978

N/A

0.312DataRank · unranked

7 citations

Xavier Leleu, Mourad Tiab, Margaret Macro, Aurore Perrot, Julie Gay +21 more

Prognostic impact of translocation t(14;16) in multiple myeloma according to the presence of additional genetic lesions

Blood Cancer Journal(2023)10.1038/s41408-023-00933-4

N/A

0DataRank · unranked

27 citations

Aurore Perrot, Titouan Cazaubiel, Xavier Leleu, Lydia Montes, Caroline Jacquet +19 more

Primary plasma cell leukemias displaying t(11;14) have specific genomic, transcriptional, and clinical features

Blood(2022)10.1182/blood.2021014968

N/A

0DataRank · unranked

29 citations

Xavier Leleu, Aurore Perrot, Salomon Manier, Laure Buisson, Sabrina Mahéo +22 more

In Multiple Myeloma, High-Risk Secondary Genetic Events Observed at Relapse Are Present From Diagnosis in Tiny, Undetectable Subclonal Populations

Journal of Clinical Oncology(2022)10.1200/jco.21.01987

N/A

0DataRank · unranked

45 citations

Mehmet Samur, Aurore Perrot, Céline Mazzotti, Marion Divoux, Titouan Cazaubiel +17 more

Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factor

Blood(2022)10.1182/blood.2022017863

N/A

0DataRank · unranked

63 citations

Alexis Talbot, Aurore Perrot, Titouan Cazaubiel, Xavier Leleu, Salomon Manier +22 more